Clazakizumab vs. Placebo - COVID-19 Infection

NCT04494724 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Infection

Interventions

DRUG: Clazakizumab
DRUG: Placebo

Sponsor

The Methodist Hospital Research Institute